[1]Heterocycles,1992,vol.33,p.391-404
Title: Molecular basis for activation of G protein-coupled receptor kinases.
Journal: The EMBO journal 20101006
Title: Cell cycle arrest and cytochrome c-mediated apoptotic induction in human lung cancer A549 cells by MCS-C2, an analogue of sangivamycin.
Journal: Journal of microbiology and biotechnology 20100201
Title: The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast cancers.
Journal: Cell cycle (Georgetown, Tex.) 20090501
Title: ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Journal: BMC cancer 20090101
Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
Title: Deciphering deazapurine biosynthesis: pathway for pyrrolopyrimidine nucleosides toyocamycin and sangivamycin.
Journal: Chemistry & biology 20080825
Title: A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues.
Journal: Bioorganic & medicinal chemistry 20080501
Title: Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Journal: Japanese journal of clinical oncology 20071101
Title: The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
Journal: The Journal of biological chemistry 20070518
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Synthesis of 2'-beta-C-methyl toyocamycin and sangivamycin analogues as potential HCV inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20050201
Title: A TOPS-MODE approach to predict adenosine kinase inhibition.
Journal: Bioorganic & medicinal chemistry letters 20040621
Title: Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors.
Journal: Brain research 20021220
Title: Phorbol myristate acetate induces ruffling of the acrosome of human sperm.
Journal: Fertility and sterility 20020701
Title: QSAR study on adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues using the hansch approach.
Journal: Bioorganic & medicinal chemistry letters 20020325
Title: Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells.
Journal: International journal of oncology 20010501
Title: Synthesis of pyrrolo[2,1-f][1,2,4]triazine C-nucleosides. Isosteres of sangivamycin, tubercidin, and toyocamycin.
Journal: Carbohydrate research 20010309
Title: Synthesis of carbocyclic analogs of 2',3'-dideoxysangivamycin, 2',3'-dideoxytoyocamycin, and 2',3'-dideoxytriciribine.
Journal: Nucleosides, nucleotides & nucleic acids 20010101
Title: Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and thiosangivamycin: the effect of certain 4- and 4,6-substituents on the antiviral activity of pyrrolo[2,3-d]pyrimidines.
Journal: Journal of medicinal chemistry 19960830
Title: Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Journal: Journal of medicinal chemistry 19960216
Title: Synthesis and antiproliferative and antiviral activity of 2'-deoxy-2'-fluoroarabinofuranosyl analogs of the nucleoside antibiotics toyocamycin and sangivamycin.
Journal: Journal of medicinal chemistry 19950929
Title: Design, synthesis, and studies on the structure activity relationships of certain pyrrolo[2,3-d]pyrimidine nucleosides and structurally related analogs as potential antineoplastic and antiviral agents.
Journal: Farmaco (Societa chimica italiana : 1989) 19910101
Title: Arabinofuranosylpyrrolo[2,3-d]pyrimidines as potential agents for human cytomegalovirus infections.
Journal: Journal of medicinal chemistry 19901201
Title: Synthesis and antiviral activity of some 7-[(2-hydroxyethoxy)methyl]pyrazolo[3,4-d]pyrimidine analogues of sangivamycin and toyocamycin.
Journal: Journal of medicinal chemistry 19900701
Title: Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives.
Journal: Antimicrobial agents and chemotherapy 19890801
Title: Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin.
Journal: Journal of medicinal chemistry 19890701
Title: Antiviral activities of 2'-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses.
Journal: Antiviral research 19881211
Title: Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus.
Journal: Antimicrobial agents and chemotherapy 19870401
Title: Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
Journal: Journal of medicinal chemistry 19870301
Title: Xylotubercidin against herpes simplex virus type 2 in mice.
Journal: Antimicrobial agents and chemotherapy 19861101
Title: Antiviral activity of C-5 substituted tubercidin analogues.
Journal: Journal of medicinal chemistry 19840301
